Josh Bilenker

Joshua H.
Bilenker is the founder of Treeline Biosciences, Inc., founded in 2021, serving as Chief Executive Officer.
Dr. Bilenker was the founder of Loxo Oncology, Inc., founded in 2013, serving as President, Chief Executive Officer, CFO & Director from 2013 to 2015.
Dr. Bilenker is currently an Independent Director at Sana Biotechnology, Inc. since 2020.
Former positions include Director at LENSAR, Inc., Independent Non-Executive Director at ViewRay Technologies, Inc., Independent Director at Sorrento Tech, Inc. from 2012 to 2015, Independent Director at ViewRay, Inc. from 2008 to 2017, Director at BioEnterprise Corp., Independent Director at T2 Biosystems, Inc. from 2014 to 2017, Director at National Comprehensive Cancer Network Foundation, Independent Director at Gossamer Bio, Inc. from 2018 to 2023, Director at Roka Bioscience, Inc. from 2012 to 2015, Operating Partner at Aisling Capital LLC from 2006 to 2019, Chief Medical Officer at US Food & Drug Administration from 2004 to 2006, Board Observer at Aragon Pharmaceuticals, Inc., and Head-Loxo Oncology Research at Eli Lilly & Co. from 2019 to 2021.
Education includes an undergraduate degree from Princeton University conferred in 1994 and a doctorate from The Johns Hopkins University School of Medicine conferred in 1999.